Philogen SpA (FRA:78Q) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 26, 2026)


FRA:78Q Philogen SpA FRA:78Q
64 GF Score
Price €22.10
GF Value €219.41
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Philogen SpA Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Philogen SpA's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

FRA:78Q vs VRTX, REGN, ALNY: Margin of Safety % (DCF Earnings Based) Comparison

For the Biotechnology subindustry, Philogen SpA's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Philogen SpA Margin of Safety % (DCF Earnings Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Philogen SpA's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Philogen SpA's Margin of Safety % (DCF Earnings Based) falls into.


FRA:78Q
64GF Score
Philogen SpA FRA:78Q
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Philogen SpA (FRA:78Q) Overvalued in 2026?

Based on GuruFocus' analysis, Philogen SpA stock appears to be undervalued. The current stock price of €22.10 is trading 89.9% below its estimated GF Value™ of €219.41. GuruFocus considers Philogen SpA to be Possible Value Trap.

Key valuation signals for FRA:78Q:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: €219.41 vs. price of €22.10 (89.9% below fair value)
  • GF Score™: 64/100 with 3 warning signs

No single metric tells the full story. See the FRA:78Q stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Philogen SpA Business Description

Other Exchanges PHIL:Italy
Address Piazza La Lizza No. 7, Siena, ITA, 53100
Philogen SpA is a biotechnology company engaged in the research and development of antibody-based therapeutics for the treatment of cancer and chronic inflammatory diseases. The company's pipeline includes products such as Nidlegy, Fibromun, Darleukin, and Dekavil, targeting oncology and other serious conditions. Geographically, the company operates in the European Union, Switzerland, and the United States of America.
64GF Score

Get the complete analysis for FRA:78Q

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€22.10
Price
€219.41
GF Value